Heart Disease News and Research

Latest Heart Disease News and Research

Adalimumab may decrease vascular inflammation in patients with psoriasis

A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease.

17 Mar 2012

Positive data from VBL Therapeutics' VB-201 Phase 2 study on psoriasis, atherosclerosis

VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.

17 Mar 2012

Obesity appears to increase risk of mortality tied to sleeping pills

Obesity appears to significantly increase the risk of death tied to sleeping pills, nearly doubling the rate of mortality even among those prescribed 18 or fewer pills in a year, researchers reported Friday.

17 Mar 2012

Dental hygiene critical for preventing endocarditis in patients with congenital heart disease

Poor dental hygiene behaviours in patients with congenital heart disease are increasing their risk of endocarditis. Teens with congenital heart disease floss, brush and visit the dentist less than their peers. But they have healthier behaviours when it comes to alcohol, cigarettes and illicit drugs.

16 Mar 2012

Warming climate may increase risk from Chagas disease

In the spring of 1835, Charles Darwin was bitten in Argentina by a "great wingless black bug," he wrote in his diary. "It is most disgusting to feel soft wingless insects, about an inch long, crawling over one's body," Darwin wrote, "before sucking they are quite thin, but afterwards round & bloated with blood."

16 Mar 2012

Unconscious racial attitudes affect positive interactions leading to the detriment of patient health

Primary care physicians who hold unconscious racial biases tend to dominate conversations with African-American patients during routine visits, paying less attention to patients' social and emotional needs and making these patients feel less involved in decision making related to their health, Johns Hopkins researchers report.

16 Mar 2012

Serious climate change-related health problems will affect the world's population

Worldwide increases in the incidences of asthma, allergies, infectious and cardiovascular diseases will result from a variety of impacts of global climate change, including rising temperatures, worsening ozone levels in urban areas, the spread of desertification, and expansions of the ranges of communicable diseases as the planet heats up, the professional organization representing respiratory and airway physicians stated in a new position paper released today.

16 Mar 2012

More than 250 Montefiore physicians named Top Doctors by Castle Connolly

More than 250 doctors from Montefiore Medical Center have been named in the Top Doctors: New York Metro Area 2012 guide, by Castle Connolly Medical Ltd. The doctors selected were among thousands who had been nominated by their peers and judged on various criteria including medical education, training, hospital appointments and disciplinary histories.

16 Mar 2012

Introducing art into nursing care improves stroke survivors' QOL

Stroke survivors who like art have a significantly higher quality of life than those who do not, according to new research. Patients who appreciated music, painting and theatre recovered better from their stroke than patients who did not.

16 Mar 2012

Experts highlight latest advances in use of biomarkers in various diseases

Over the last few decades there has been an explosion in the discovery of biomarkers for diagnosis, disease monitoring, and prognostic evaluation. In the April issue of Translational Research, entitled "Biomarkers: New Tools of Modern Medicine," an international group of medical experts explores the promise and challenges of biomarker discovery and highlights the latest advances in the use of biomarkers in various diseases.

16 Mar 2012

Depression increases risk of death in PCI patients

Depression increases the risk of death in patients who have a coronary stent implanted. After seven years of follow up, depressed patients were 1.5 times more likely to have died than non-depressed patients. The findings were independent of age, gender, clinical characteristics, anxiety and the distressed (Type D) personality.

16 Mar 2012

UM, Shock Trauma partner to train dental students, residents

The University of Maryland's (UM) School of Dentistry has teamed up with the UM School of Medicine's R Adams Cowley Shock Trauma Center for training future dentists to respond efficiently and effectively to life threatening medical emergencies in a dental setting.

16 Mar 2012

Third International Symposium on Thymosins in Health and Disease to take place on GW campus

The George Washington University is host to the world's leaders in the area of research that focuses on Thymosins- small proteins present in many animal tissues that have diverse biological activities- Two in particular, thymosins α1 and β4, have potentially important uses in medicine, and research has already progressed from the laboratory to the clinic.

16 Mar 2012

OHRI, uOttawa to lead first stem cell therapy trial for septic shock

A team of researchers from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa (uOttawa) has been awarded $367,000 from the Canadian Institutes of Health Research (CIHR) and $75,000 from the Stem Cell Network to lead the first clinical trial in the world of a stem cell therapy for septic shock.

16 Mar 2012

Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HS

Abbott today announced the initiation of two Phase 3 clinical trials designed to evaluate the safety and efficacy of an investigational use of HUMIRA (adalimumab) in adult patients with moderate to severe hidradenitis suppurativa.

16 Mar 2012

Health Canada approves Mylan-Rosuvastatin Calcium Tablets

Mylan Pharmaceuticals ULC, the Canadian subsidiary of Mylan Inc., today received approval from Health Canada for Mylan-Rosuvastatin Calcium Tablets, 5mg, 10mg, 20mg and 40mg. Mylan-Rosuvastatin is the generic version of Astra Zeneca's Crestor Tablets, which are used for the management of primary hypercholesterolaemia, mixed dyslipidaemia, and familial hypercholesterolaemia.

16 Mar 2012

Patients with early stage MPM may be eligible for aggressive multi-modality therapy

Patients with early stage malignant pleural mesothelioma (MPM), a cancer that develops in the lining of the lungs, may be eligible for aggressive multi-modality therapy involving surgery, radiotherapy and chemotherapy.

16 Mar 2012

Light-to-moderate drinking may reduce risk of stroke in women

Light-to-moderate alcohol consumption has been consistently associated with lower risk of heart disease, but data for stroke are less certain, especially among women.

16 Mar 2012

CSL Behring initiates FCH Phase III trial to control bleeding during cardiovascular surgery

CSL Behring announced today that the first patient has been treated as part of the REPLACE Phase III clinical trial evaluating the efficacy and safety of fibrinogen concentrate (Human) (FCH) in controlling microvascular bleeding during aortic aneurysm surgery.

16 Mar 2012

diaDexus fourth quarter total revenues increase 48% to $4.9 million

diaDexus, Inc.a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced financial results for the 2011 fourth quarter and year-end.

16 Mar 2012

Heart Disease News and Research

Latest Heart Disease News and Research

Adalimumab may decrease vascular inflammation in patients with psoriasis

Positive data from VBL Therapeutics' VB-201 Phase 2 study on psoriasis, atherosclerosis

Obesity appears to increase risk of mortality tied to sleeping pills

Dental hygiene critical for preventing endocarditis in patients with congenital heart disease

Warming climate may increase risk from Chagas disease

Unconscious racial attitudes affect positive interactions leading to the detriment of patient health

Serious climate change-related health problems will affect the world's population

More than 250 Montefiore physicians named Top Doctors by Castle Connolly

Introducing art into nursing care improves stroke survivors' QOL

Experts highlight latest advances in use of biomarkers in various diseases

Depression increases risk of death in PCI patients

UM, Shock Trauma partner to train dental students, residents

Third International Symposium on Thymosins in Health and Disease to take place on GW campus

OHRI, uOttawa to lead first stem cell therapy trial for septic shock

Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HS

Health Canada approves Mylan-Rosuvastatin Calcium Tablets

Patients with early stage MPM may be eligible for aggressive multi-modality therapy

Light-to-moderate drinking may reduce risk of stroke in women

CSL Behring initiates FCH Phase III trial to control bleeding during cardiovascular surgery

diaDexus fourth quarter total revenues increase 48% to $4.9 million

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in